Understanding how nuclear cGAS regulates immune responses
Regulation and Function of Nuclear cGAS
This study is looking at how a protein called cGAS helps our immune system spot DNA viruses and how it might be linked to autoimmune diseases and cancer, with the goal of finding new ways to boost our body's defenses against infections and tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10897011 on NIH RePORTER |
What this research studies
This research investigates the role of nuclear cGAS in detecting DNA viruses and its implications for autoimmune diseases and cancer immunity. By exploring how cGAS is regulated within the nucleus, the study aims to uncover mechanisms that prevent its activation against the body's own DNA. The researchers are developing innovative tools to track cGAS behavior during infections and its interactions with nucleic acids. This could lead to new insights into how the immune system can be harnessed to fight infections and tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases or those at risk for DNA virus infections.
Not a fit: Patients with conditions unrelated to DNA virus infections or autoimmune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for autoimmune diseases and improved cancer treatments by enhancing the body's immune response.
How similar studies have performed: Previous research has shown promise in understanding immune responses related to cGAS, indicating that this approach could lead to significant advancements.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Stetson, Daniel B — University of Washington
- Study coordinator: Stetson, Daniel B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.